Home
About
FAQ
History (22)
Tuberous sclerosis complex and neurofibromatosis type 1: the two most common neurocutaneous diseases.
Behavioral facilitation of medical treatment of headache: implications of noncompliance and strategies for improving adherence.
CD138 plasma cells may predict brain metastasis recurrence following resection and stereotactic radiosurgery.
Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer.
Medication-based versus target-based lipid management.
See All 22 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Medication-based versus target-based lipid management.
Fazio S, Shapiro MD. Medication-based versus target-based lipid management. J Diabetes. 2018 Oct; 10(10):789-792.
View in:
PubMed
subject areas
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hyperlipidemias
Medication Adherence
Practice Guidelines as Topic
authors with profiles
Michael D. Shapiro DO, MCR